PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-4105

  1. 5,010 Posts.
    lightbulb Created with Sketch. 654
    Did u ask Bene why they haven’t bought into Paradigm??
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.